Propensity score ‐matched comparative analyses of simultaneously administered fixed‐ratio iGlarLixi (LixiLan) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - July 5, 2018 Category: Endocrinology Authors: Julio Rosenstock MD , Yehuda Handelsman MD , Josep Vidal MD PhD , F. Javier Ampudia Blasco MD PhD , Francesco Giorgino MD PhD , Minzhi Liu PhD , Riccardo Perfetti MD PhD , Juris J. Meier MD Source Type: research